Total Payments
$17,121
2024 Payments
$1,277
Companies
36
Transactions
197
Medicare Patients
2,658
Medicare Billing
$190,140
Payment Breakdown by Category
Consulting$7,875 (46.0%)
Travel$4,979 (29.1%)
Food & Beverage$3,463 (20.2%)
Other$715.00 (4.2%)
Education$89.00 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $7,875 | 12 | 46.0% |
| Travel and Lodging | $4,979 | 15 | 29.1% |
| Food and Beverage | $3,463 | 166 | 20.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $715.00 | 3 | 4.2% |
| Education | $89.00 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UROVANT SCIENCES INC | $11,422 | 33 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $2,444 | 17 | $0 (2024) |
| ABBVIE INC. | $813.32 | 37 | $0 (2024) |
| Rochester Medical Corporation | $337.18 | 15 | $0 (2022) |
| Janssen Biotech, Inc. | $330.77 | 16 | $0 (2024) |
| Astellas Pharma US Inc | $298.73 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $268.85 | 11 | $0 (2024) |
| Progenics Pharmaceuticals, Inc. | $139.68 | 5 | $0 (2023) |
| Olympus America Inc. | $132.05 | 7 | $0 (2023) |
| Antares Pharma, Inc. | $100.25 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,277 | 41 | Sumitomo Pharma America, Inc. ($331.08) |
| 2023 | $2,758 | 40 | Sumitomo Pharma America, Inc. ($2,113) |
| 2022 | $8,911 | 72 | UROVANT SCIENCES INC ($7,952) |
| 2021 | $4,175 | 44 | UROVANT SCIENCES INC ($3,470) |
All Payment Transactions
197 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: UROLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/22/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/18/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: UROLOGY | ||||||
| 10/30/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: ONCOLOGY | ||||||
| 10/27/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Oncology | ||||||
| 10/22/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/16/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $33.94 | General |
| Category: Immunotherapy | ||||||
| 10/09/2024 | Avation Medical, Inc. | Vivally (Device) | Food and Beverage | Cash or cash equivalent | $23.08 | General |
| Category: Device | ||||||
| 10/02/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: UROLOGY | ||||||
| 09/30/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $14.58 | General |
| 09/23/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/11/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/05/2024 | Sumitomo Pharma America, Inc. | — | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| 08/22/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $32.40 | General |
| Category: Pain Management | ||||||
| 08/12/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $30.40 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 07/23/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Oncology | ||||||
| 06/10/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: ONCOLOGY | ||||||
| 05/22/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $89.00 | General |
| 05/21/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: Immunotherapy | ||||||
| 05/13/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 527 | 665 | $125,628 | $33,493 |
| 2022 | 13 | 767 | 982 | $199,017 | $57,489 |
| 2021 | 12 | 834 | 1,096 | $212,677 | $65,328 |
| 2020 | 13 | 530 | 688 | $126,440 | $33,830 |
Total Patients
2,658
Total Services
3,431
Medicare Billing
$190,140
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 95 | $21,660 | $8,346 | 38.5% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 22 | 22 | $27,280 | $5,659 | 20.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 50 | 54 | $13,134 | $4,607 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 67 | $10,921 | $4,011 | 36.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 48 | 60 | $8,400 | $3,308 | 39.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 26 | $6,760 | $2,417 | 35.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 29 | 37 | $2,960 | $1,319 | 44.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 13 | $2,600 | $1,101 | 42.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 16 | 16 | $2,833 | $970.35 | 34.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 63 | 94 | $9,400 | $839.68 | 8.9% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 22 | 22 | $12,320 | $510.40 | 4.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 91 | 140 | $2,800 | $305.80 | 10.9% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 19 | 19 | $4,560 | $98.23 | 2.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 149 | 219 | $52,617 | $19,514 | 37.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 91 | 120 | $27,164 | $10,334 | 38.0% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2022 | 26 | 27 | $33,480 | $7,388 | 22.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 85 | 105 | $18,296 | $6,528 | 35.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 57 | 72 | $10,574 | $3,677 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 52 | $8,377 | $3,086 | 36.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 27 | 27 | $5,400 | $1,968 | 36.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 20 | $5,200 | $1,915 | 36.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 26 | 38 | $3,170 | $1,064 | 33.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 84 | 105 | $10,500 | $918.79 | 8.8% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2022 | 26 | 27 | $15,120 | $643.17 | 4.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 104 | 144 | $2,880 | $319.23 | 11.1% |
About Julia Buesser
Julia Buesser is a Adult Health healthcare provider based in Gurnee, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2015. The National Provider Identifier (NPI) number assigned to this provider is 1013390491.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Julia Buesser has received a total of $17,121 in payments from pharmaceutical and medical device companies, with $1,277 received in 2024. These payments were reported across 197 transactions from 36 companies. The most common payment nature is "Consulting Fee" ($7,875).
As a Medicare-enrolled provider, Buesser has provided services to 2,658 Medicare beneficiaries, totaling 3,431 services with total Medicare billing of $190,140. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Adult Health
- Location Gurnee, IL
- Active Since 07/03/2015
- Last Updated 07/12/2019
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1013390491
Products in Payments
- GEMTESA (Drug) $13,587
- LUPRON DEPOT (Drug) $631.87
- ERLEADA (Drug) $306.33
- KEYTRUDA (Biological) $252.37
- BOTOX (Biological) $211.01
- Myrbetriq (Drug) $190.39
- PYLARIFY (Drug) $139.68
- iTIND System (Device) $105.43
- XYOSTED (Drug) $79.95
- PROVENGE (Drug) $63.82
- ANKTIVA (Drug) $61.69
- LoFric (Device) $54.81
- AQUABEAM ROBOTIC SYSTEM (Device) $52.82
- ADSTILADRIN (Biological) $46.22
- CAMCEVI (Drug) $44.37
- UroLift System (Device) $44.28
- LYNPARZA (Drug) $43.07
- JATENZO (Drug) $34.56
- Axumin (Drug) $32.94
- Exparel (Drug) $32.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.